Shopping Cart
Remove All
Your shopping cart is currently empty
Tetrahexyldecyl ascorbate (BV-OSC) is a lipophilic precursor of ascorbic acid, a more stable and permeable form of vitamin C. It is a potent anti-photo-aging and anti-hyperpigmentation antioxidant that inhibits MMP enzyme activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 g | $31 | - | In Stock | |
| 5 g | $62 | 7-10 days | 7-10 days | |
| 1 mL x 10 mM (in DMSO) | $29 | - | In Stock |
| Description | Tetrahexyldecyl ascorbate (BV-OSC) is a lipophilic precursor of ascorbic acid, a more stable and permeable form of vitamin C. It is a potent anti-photo-aging and anti-hyperpigmentation antioxidant that inhibits MMP enzyme activity. |
| In vitro | Tetrahexyldecyl ascorbate, either alone or in combination with AZ, was applied to human keratinocytes (HaCaT) and dermal fibroblasts (nHDF, aHDF), and incubated for 0.5 to 3 hours. After treatment, cell viability was assessed using CCK-8, ELISA, and gene chip technologies. The Results showed that Tetrahexyldecyl ascorbate reduced cell viability under oxidative stress, while its combination with AZ significantly enhanced cell activity. The combination therapy upregulated genes related to phospholipid homeostasis and keratinocyte differentiation, inhibited the expression of MMP1 and MMP7, and promoted collagen synthesis in dermal fibroblasts [1]. |
| Synonyms | Nikkol VC-IP, IPAA, BV-OSC, Ascorbyl tetra-2-hexyldecanoat |
| Molecular Weight | 1129.76 |
| Formula | C70H128O10 |
| Cas No. | 183476-82-6 |
| Smiles | [C@H](OC(C(CCCCCCCC)CCCCCC)=O)(COC(C(CCCCCCCC)CCCCCC)=O)[C@@]1(C(OC(C(CCCCCCCC)CCCCCC)=O)=C(OC(C(CCCCCCCC)CCCCCC)=O)C(=O)O1)[H] |
| Relative Density. | 0.928-0.941 g/cm3 at 20℃ |
| Color | Transparent |
| Appearance | Liquid |
| Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 180 mg/mL (159.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (4.43 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.